Skip to main content
Log in

Australian University Students’ Attitudes Towards the Acceptability and Regulation of Pharmaceuticals to Improve Academic Performance

  • Original Paper
  • Published:
Neuroethics Aims and scope Submit manuscript

Abstract

There is currently little empirical information about attitudes towards cognitive enhancement - the use of pharmaceutical drugs to enhance normal brain functioning. It is claimed this behaviour most commonly occurs in students to aid studying. We undertook a qualitative assessment of attitudes towards cognitive enhancement by conducting 19 semi-structured interviews with Australian university students. Most students considered cognitive enhancement to be unacceptable, in part because they believed it to be unethical but there was a lack of consensus on whether it was similar or different to steroid use in sport. There was support for awareness campaigns and monitoring of cognitive enhancement use of pharmaceutical drugs. An understanding of student attitudes towards cognitive enhancement is important in formulating future policy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sahakian, B.J., and S. Morein-Zamir. 2011. Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology 25(2): 197–204.

    Article  Google Scholar 

  2. Pieters, T., and S. Snelders. 2009. Psychotropic drug use: between healing and enhancing the mind. Neuroethics 2(2): 63–73.

    Article  Google Scholar 

  3. Bostrom, N., and A. Sandberg. 2009. Cognitive enhancement: methods, ethics, regulatory challenges. Science and Engineering Ethics 15(3): 311–341.

    Article  Google Scholar 

  4. Schermer, M. 2008. On the argument that enhancement is "cheating". Journal of Medical Ethics 34(2): 85–88.

    Article  Google Scholar 

  5. McCabe, S.E., J.R. Knight, C.J. Teter, and H. Wechsler. 2005. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100(1): 96–106.

    Article  Google Scholar 

  6. Franke, A.G., C. Bonertz, M. Christmann, M. Huss, A. Fellgiebel, E. Hildt, and K. Lieb. 2011. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 44(2): 60–66.

    Article  Google Scholar 

  7. Lucke, J.C., S. Bell, B. Partridge, and W.D. Hall. 2011. Deflating the Neuroenhancement Bubble. AJOB Neuroscience 2(4): 38–43.

    Article  Google Scholar 

  8. Chatterjee, A. 2009. Is it acceptable for people to take methylphenidate to enhance performance? British Medical Journal 338: 1532–1533.

    Article  Google Scholar 

  9. Forlini, C., and E. Racine. 2009. Autonomy and coercion in academic "cognitive enhancement" using methylphenidate: perspectives of key stakeholders. Neuroethics 2(3): 163–177.

    Article  Google Scholar 

  10. Forlini, C., and E. Racine. 2010. Stakeholder perspectives and reactions to “academic” cognitive enhancement: unsuspected meaning of ambivalence and analogies. Public Understanding of Science. doi:10.1177/0963662510385062.

  11. Appel, J.M. 2008. When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology. Joural of Medical Ethics 34(8): 616–618.

    Article  Google Scholar 

  12. Schoomaker, E.B. 2007. Military medical research on cognitive performance: the warfighter's competitive edge. Aviation, Space, and Environmental Medicine. Special Issue: Operational applications of cognitive performance enhancement technologies 78(5, Sect II, Suppl): B4–B6.

    Google Scholar 

  13. Warren, O.J., D.R. Leff, T. Athanasiou, C. Kennard, and A. Darzi. 2009. The neurocognitive enhancement of surgeons: an ethical perspective. Journal of Surgical Research 152(1): 167–172.

    Article  Google Scholar 

  14. Dees, R.H. 2007. Better brains, better selves? The ethics of neuroenhancements. Kennedy Institute of Ethics Journal 17(4): 371–395.

    Article  Google Scholar 

  15. DeSantis, A., S.M. Noar, and E.M. Webb. 2010. Speeding through the frat house: a qualitative exploration of nonmedical ADHD stimulant use in fraternities. Journal of Drug Education 40(2): 157–171.

    Article  Google Scholar 

  16. DeSantis, A.D., and A.C. Hane. 2010. "Adderall is definitely not a drug": justifications for the illegal use of ADHD stimulants. Substance Use & Misuse 45(1–2): 31–46.

    Article  Google Scholar 

  17. DeSantis, A., E.M. Webb, and S.M. Noar. 2008. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. Journal of American College Health 57(3): 315–324.

    Article  Google Scholar 

  18. Cakic, V. 2009. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics 35(10): 611–615.

    Article  Google Scholar 

  19. Greely, H., B. Sahakian, J. Harris, R.C. Kessler, M. Gazzaniga, P. Campbell, and M.J. Farah. 2008. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456(7223): 702–705.

    Article  Google Scholar 

  20. Singh, I., and K.J. Kelleher. 2010. Neuroenhancement in young people: proposal for research, policy, and clinical management. AJOB Neuroscience 1(1): 3–16.

    Article  Google Scholar 

  21. DeSantis, A., S.M. Noar, and E.M. Webb. 2009. Nonmedical ADHD stimulant use in fraternities. Journal of Studies on Alcohol and Drugs 70(6): 952–954.

    Google Scholar 

  22. Hansen, E.C. 2006. Successful qualitative health research. Crows Nest, NSW: Allen & Unwin.

    Google Scholar 

  23. Hill, C.E., S. Knox, B.J. Thompson, E.N. Williams, S.A. Hess, and N. Ladany. 2005. Consensual qualitative research: an update. Journal of Counseling Psychology 52(2): 196–205.

    Article  Google Scholar 

  24. Hill, C.E., B.J. Thompson, and E.N. Williams. 1997. A guide to conducting consensual qualitative research. The Counseling Psychologist 25(4): 517–572.

    Article  Google Scholar 

  25. Fox, N.J., and K.J. Ward. 2008. Pharma in the bedroom … and the kitchen … the pharmaceuticalisation of daily life. Sociology of Health & Illness 30(6): 856–868.

    Article  Google Scholar 

  26. Hall, W. 2004. Feeling 'better than well:' can our experiences with psychoactive drugs help us to meet the challenges of novel neuroenhancement methods? EMBO Reports 5(12): 1105–1109.

    Article  Google Scholar 

  27. Farah, M.J. 2002. Emerging ethical issues in neuroscience. Nature Neuroscience 5(11): 1123–1129.

    Article  Google Scholar 

  28. Forlini, C., and E. Racine. 2009. Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics 10: 9. doi:10.1186/1472-6939-10-9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brad Partridge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bell, S., Partridge, B., Lucke, J. et al. Australian University Students’ Attitudes Towards the Acceptability and Regulation of Pharmaceuticals to Improve Academic Performance. Neuroethics 6, 197–205 (2013). https://doi.org/10.1007/s12152-012-9153-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12152-012-9153-9

Keywords

Navigation